Summary:
He works closely with the International Association for Study of Lung Cancer (IASLC) – another global organisation dedicated to lung cancer. It is a leading resource provider for the practice of clinical oncology in both academic and community settings as well as for the oncology research. Dr Singh leads the multidisciplinary thoracic oncology group at the PGIMER and specialises in thoracic medical oncology, especially targeted therapies and immunotherapy, for advanced/metastatic non-small cell lung cancer (NSCLC). Dr Singh took over as the chair at the 54th annual meeting of the ASCO held in the first week of June at Chicago, USA. The ASCO is the world’s largest professional body with a global network of nearly 45,000 oncology professionals (individuals working in the area of cancer care)..